Search Results 921-930 of 14804 for anti-TNF drugs

  1. Rheumatology - Overview - Mayo Clinic

    Rheumatologists at Mayo Clinic work in a team environment to provide state-of-the-art diagnosis and treatment for autoimmune and inflammatory diseases that ...

  2. Rheumatoid factor - Mayo Clinic

    A rheumatoid factor test is one of a group of blood tests mainly used to help pinpoint a diagnosis of rheumatoid arthritis. These other tests may include: Anti- ...

  3. Glycopyrrolate And Formoterol (Inhalation Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  4. Flurbiprofen (Oral Route) Before Using - Mayo Clinic

    Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. · Pediatric · Geriatric · Drug ...

  5. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

    This study aims to assess if adding immunotherapy to these drugs is better or worse than the usual approach for treatment of this cancer. Participation ...

  6. Atezolizumab (Intravenous Route) Precautions - Mayo Clinic

    Use an effective form of birth control to keep from getting pregnant during treatment with this medicine and for at least 5 months after the last dose. If you ...

  7. Entrectinib (Oral Route) Precautions - Mayo Clinic

    Cancer medicines can cause constipation, diarrhea, nausea, or vomiting in most people, sometimes even after receiving medicines to prevent it. Ask your doctor ...

  8. TEN - Symptoms and causes - Mayo Clinic

    Toxic epidermal necrolysis (TEN) is a rare, life-threatening skin reaction, usually caused by a medication. It's a severe form of Stevens-Johnson syndrome ...

  9. A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) (Morpheus-Gastric Cancer) - Mayo Clinic

    A Phase Ib/II, open label, multi-center, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ...

  10. A Study to Compare Nivolumab or Brentuximab Vedotin Plus Combination Chemotherapy to Treat Patients with Newly-diagnosed Stage III-IV Classic Hodgkin Lymphoma - Mayo Clinic

    Drugs used in chemotherapy, such as doxorubicin, vinblastine ... Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy ...